Table 3 Availability of key malaria commodities
From: Determinants of malaria testing at health facilities: the case of Uganda
Characteristics | N (1085) | Malaria RDTs n (%) | Artemether lumefantrine n (%) | Sulfadoxine–pyrimethamine SP n (%) |
|---|---|---|---|---|
Type of facility | ||||
Hospital | 32 | 28 (87.5) | 28 (87.5) | 31 (100) |
HC IV | 56 | 50 (89.3) | 51 (91.1) | 54 (96.4) |
HC III | 409 | 393 (96.1) | 354 (86.5) | 401 (98.0) |
HC II | 539 | 482 (89.4) | 444 (82.4) | 496 (92.0) |
Clinic/drug shop | 44 | 40 (90.9) | 38 (86.4) | 41 (93.2) |
Ownership of facility | ||||
Public | 828 | 761 (91.9) | 691 (83.5) | 679 (82.0) |
Private for profit | 73 | 63 (86.3) | 61 (83.6) | 60 (82.2) |
Private not for profit | 184 | 172 (91.8) | 166 (90.2) | 149 (81.0) |
Location of facility | ||||
Rural | 873 | 807 (92.4) | 732 (83.9) | 718 (82.3) |
Urban | 212 | 189 (89.2) | 186 (87.7) | 170 (80.2) |
Overall | 1085 | 996 (91.8) | 918 (84.6) | 888 (81.8) |